These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18499716)

  • 1. Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population.
    Grijalva CG; Chung CP; Stein CM; Mitchel EF; Griffin MR
    Rheumatology (Oxford); 2008 Jul; 47(7):1061-4. PubMed ID: 18499716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Rheumatoid Arthritis and Drug Dispensing Patterns Among Medicaid and Medicaid-Medicare Dually Eligible Beneficiaries in Puerto Rico.
    Hernández-Muñoz JJ; Wei W; Sierra-Zorita R
    Arthritis Care Res (Hoboken); 2021 Feb; 73(2):199-206. PubMed ID: 32475025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
    Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
    Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of drug use in rheumatoid arthritis.
    Bérard A; Solomon DH; Avorn J
    J Rheumatol; 2000 Jul; 27(7):1648-55. PubMed ID: 10914846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
    Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
    Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription patterns and trends in anti-rheumatic drug use based on a large-scale claims database in Japan.
    Katada H; Yukawa N; Urushihara H; Tanaka S; Mimori T; Kawakami K
    Clin Rheumatol; 2015 May; 34(5):949-56. PubMed ID: 24420724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delay in initiation of DMARD or anti-inflammatory therapy in patients newly diagnosed with rheumatoid arthritis: An analysis of United States Military Health System TRICARE beneficiaries.
    Kimsey L; Weissman JS; Patel A; Drew A; Koehlmoos T; Sparks JA
    Semin Arthritis Rheum; 2019 Apr; 48(5):821-827. PubMed ID: 30190154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis.
    Jin Y; Desai RJ; Liu J; Choi NK; Kim SC
    Arthritis Res Ther; 2017 Jul; 19(1):159. PubMed ID: 28679392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
    Finckh A; Bansback N; Marra CA; Anis AH; Michaud K; Lubin S; White M; Sizto S; Liang MH
    Ann Intern Med; 2009 Nov; 151(9):612-21. PubMed ID: 19884622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial/ethnic differences in the use of biologic disease-modifying antirheumatic drugs among California Medicaid rheumatoid arthritis patients.
    Chu LH; Portugal C; Kawatkar AA; Stohl W; Nichol MB
    Arthritis Care Res (Hoboken); 2013 Feb; 65(2):299-303. PubMed ID: 22807272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996.
    Ward MM; Fries JF
    J Rheumatol; 1998 Mar; 25(3):408-16. PubMed ID: 9517756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database.
    Edwards CJ; Arden NK; Fisher D; Saperia JC; Reading I; Van Staa TP; Cooper C
    Rheumatology (Oxford); 2005 Nov; 44(11):1394-8. PubMed ID: 16030083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of medication use during pregnancy in rheumatoid arthritis.
    Kuriya B; Hernández-Díaz S; Liu J; Bermas BL; Daniel G; Solomon DH
    Arthritis Care Res (Hoboken); 2011 May; 63(5):721-8. PubMed ID: 21557526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial disease modifying antirheumatic drugs and prednisolone prescriptions for patients with rheumatoid arthritis: a 15-year study.
    Osiri M; Akkasilpa S; Deesomchok U
    J Med Assoc Thai; 2000 Mar; 83(3):217-24. PubMed ID: 10808674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Descriptive study of the use of DMARD in patients with rheumatoid arthritis or persistent arthritis who start drug treatment in Spain (FIRST)].
    Blanco FJ; Ballina J; Carbonell J; Martín-Mola E; Tornero J; Ramírez E; Galván J
    Reumatol Clin; 2011; 7(2):88-93. PubMed ID: 21794790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
    Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
    Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End-stage renal disease in patients with rheumatoid arthritis.
    Paudyal S; Yang FM; Rice C; Chen CC; Skelton M; Bethel M; Brown S; Nahman NS; Carbone L
    Semin Arthritis Rheum; 2017 Feb; 46(4):418-422. PubMed ID: 27591827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons.
    Graudal N; Jürgens G
    Arthritis Rheum; 2010 Oct; 62(10):2852-63. PubMed ID: 20560138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief Report: Intensification to Triple Therapy After Treatment With Nonbiologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States From 2009 to 2014.
    Sparks JA; Krumme AA; Shrank WH; Matlin OS; Brill G; Pezalla EJ; Choudhry NK; Solomon DH
    Arthritis Rheumatol; 2016 Jul; 68(7):1588-95. PubMed ID: 26866506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.